ANTIHISTAMI

NES IN 2026

Allergic Rhinitis, Urticaria, Insect Stings, Climate Change, Air Pollution, Pediatric Allergy, and Evidence-Based Strategies to Reduce Repeat Visits in Primary Care and Emergency Medicine

Scientific and Clinical Review Updated to 2026

DrRamonReyesMD ⚕️
EMS Solutions International
https://emssolutionsint.blogspot.com

---

ABSTRACT

Primary Care physicians, Emergency Medicine clinicians, pediatricians, and family physicians throughout Spain and Europe are increasingly reporting the same observation:

"Patients who have never been allergic before are now presenting with allergic symptoms."

Current evidence suggests that this perception reflects a genuine epidemiological phenomenon rather than mere anecdotal experience.

Climate change, rising atmospheric carbon dioxide concentrations, urban pollution, prolonged growing seasons, altered rainfall patterns, and increasing airborne allergen loads are contributing to longer and more intense allergy seasons throughout Europe.

The practical consequence is a growing number of patients presenting with:

• Allergic rhinitis
• Conjunctivitis
• Urticaria
• Chronic pruritus
• Insect sting reactions
• Allergic cough
• Cutaneous hyperreactivity

This review analyzes the environmental drivers behind this phenomenon and provides a practical evidence-based approach to antihistamine use in adults and children, with particular emphasis on reducing unnecessary corticosteroid exposure and preventing repeat consultations.

---

INTRODUCTION

Over the last decade, allergic diseases have become increasingly recognized as a major public health challenge.

The European Climate and Health Observatory, the European Environment Agency (EEA), and Copernicus Atmosphere Monitoring Service (CAMS) have documented substantial changes in airborne pollen patterns across Europe.

Multiple environmental factors contribute to this trend:

• Climate change
• Rising temperatures
• Increased atmospheric CO₂
• Urban pollution
• Heat waves
• Extreme weather events
• Prolonged vegetation periods
• Increased allergenicity of pollens

As a result, allergy seasons are starting earlier, lasting longer, and affecting larger populations than previously observed.

---

WHAT IS HAPPENING IN SPAIN?

Spain represents a particularly important case study because of its climatic diversity and extensive exposure to highly allergenic vegetation.

Major respiratory allergens include:

Grass Pollens

Grass pollen remains one of the most important respiratory allergens in Spain and across Europe.

In certain regions, grass pollen accounts for the majority of seasonal allergic rhinitis cases.

---

Olive Tree Pollen

Especially relevant in:

• Andalusia
• Castilla-La Mancha
• Extremadura
• Mediterranean regions

High-pollen years can generate significant increases in healthcare utilization.

---

Cypress Pollen

Increasingly recognized as a major winter and early spring allergen.

Recent seasons have demonstrated earlier onset and longer persistence.

---

Parietaria

Particularly important in Mediterranean urban environments.

Can remain clinically relevant for extended periods throughout the year.

---

Plane Tree Pollen

Common in urban settings and associated with seasonal respiratory symptoms.

---

THE REALITY OF CLINICAL PRACTICE

Patients frequently present with:

• Persistent itching
• Allergic rhinitis
• Urticaria
• Insect sting reactions
• Allergic conjunctivitis
• Chronic cough
• Cutaneous hypersensitivity

Many receive:

• Dexchlorpheniramine (Polaramine®)
• Corticosteroids
• Short courses of antihistamines

Then return a few days later.

Not because the initial treatment failed.

But because the allergenic stimulus remains present.

---

THE MOST COMMON CLINICAL ERROR

The most frequent mistake is treating persistent allergic conditions as isolated acute events.

This leads to:

• Repeat visits
• Repeated corticosteroid injections
• Repeated first-generation antihistamine administration
• Increased healthcare burden

The modern clinical question is not:

"How do I treat today's symptoms?"

The modern question is:

"How do I prevent the next three visits?"

---

FIRST- VS SECOND-GENERATION ANTIHISTAMINES

First-Generation Antihistamines

Examples:

• Dexchlorpheniramine
• Diphenhydramine
• Hydroxyzine

Common adverse effects:

• Sedation
• Cognitive impairment
• Reduced school performance
• Reduced driving safety
• Anticholinergic effects
• Paradoxical agitation in children

These drugs still have selected indications but should not be considered first-line chronic therapy.

---

Second-Generation Antihistamines

Examples:

• Bilastine
• Cetirizine
• Levocetirizine
• Desloratadine
• Loratadine
• Fexofenadine
• Rupatadine
• Ebastine

Advantages:

• Lower sedation
• Better tolerability
• Once-daily dosing
• Improved quality of life
• Better adherence

---

PRACTICAL ADULT RANKING FOR 2026

1. Bilastine

My Preferred Choice in 2026

Standard adult dose:

20 mg orally once daily.

Advantages:

• Minimal sedation
• Excellent tolerability
• Very low interaction potential
• Effective in allergic rhinitis
• Effective in chronic urticaria

Important consideration:

Should be taken one hour before or two hours after food or fruit juice.

Off-label Dose Escalation

For chronic spontaneous urticaria:

• 40 mg/day
• 60 mg/day
• 80 mg/day

International urticaria guidelines support increasing second-generation antihistamines up to four times the licensed dose when standard treatment fails.

---

2. Cetirizine

The most versatile antihistamine in Primary Care.

Standard dose:

10 mg daily.

Advantages:

• Rapid onset
• Affordable
• Widely available
• Extensive clinical experience

Limitation:

More sedation than bilastine, desloratadine, or fexofenadine.

Off-label Escalation

• 20 mg/day
• 30 mg/day
• 40 mg/day

Particularly useful in chronic urticaria.

---

3. Levocetirizine

Standard dose:

5 mg daily.

Advantages:

• Potent antihistamine effect
• Useful in chronic urticaria
• Convenient dosing

Off-label Escalation

Up to 20 mg/day under specialist supervision.

---

4. Desloratadine

Standard dose:

5 mg daily.

Advantages:

• Low sedation
• Excellent safety profile

Limitation:

Less robust evidence for high-dose escalation compared with cetirizine or bilastine.

---

5. Fexofenadine

Standard dose:

120–180 mg daily depending on indication.

Advantages:

• Minimal sedation
• Excellent choice for drivers, pilots, and safety-sensitive occupations

---

PEDIATRIC ALLERGY MANAGEMENT IN 2026

The goal in pediatric patients is not simply symptom control.

The goal is:

• Effective symptom suppression
• Preservation of sleep quality
• Maintenance of school performance
• Avoidance of unnecessary corticosteroids
• Reduction of repeat visits

Second-generation antihistamines are preferred whenever possible.

---

PEDIATRIC PRACTICAL RANKING

1. Bilastine

Children 6–11 years (≥20 kg):

10 mg once daily.

Adolescents ≥12 years:

20 mg once daily.

Advantages:

• Minimal sedation
• Excellent tolerability
• Once-daily dosing
• Low impact on learning and attention

---

2. Cetirizine

One of the most useful pediatric antihistamines.

Typical doses:

2–5 years:

2.5–5 mg daily.

6–11 years:

5–10 mg daily.

≥12 years:

10 mg daily.

Advantages:

• Affordable
• Rapid onset
• Extensive pediatric experience

---

3. Levocetirizine

Typical doses:

2–5 years:

1.25–2.5 mg daily.

6–11 years:

2.5–5 mg daily.

≥12 years:

5 mg daily.

---

4. Desloratadine

Typical doses:

1–5 years:

1.25 mg daily.

6–11 years:

2.5 mg daily.

≥12 years:

5 mg daily.

Advantages:

• Very low sedation
• Excellent tolerability

---

WHAT I DISLIKE IN 2026

Routine Long-Term Polaramine®

Dexchlorpheniramine still has a role.

However, for chronic pediatric management it may cause:

• Sedation
• REM sleep disruption
• Reduced school performance
• Behavioral changes
• Paradoxical excitation

Modern international guidelines favor second-generation antihistamines whenever possible.

---

INSECT STINGS: A PRACTICAL APPROACH

For uncomplicated local reactions:

Day 1:

• Local care
• Cold packs
• Antihistamine
• Corticosteroid only if truly indicated

If symptoms improve:

Days 2–10:

• Bilastine
• Cetirizine

Avoid automatically repeating:

• Intramuscular corticosteroids
• Intramuscular dexchlorpheniramine

when the patient is already improving.

---

WHEN TO WORRY

Urgent reassessment is required if any of the following occur:

• Dyspnea
• Stridor
• Wheezing
• Progressive angioedema
• Laryngeal involvement
• Syncope
• Hypotension
• Anaphylaxis

---

ANAPHYLAXIS

The first-line treatment is:

Intramuscular Epinephrine

Antihistamines do not reverse life-threatening airway obstruction or shock.

Corticosteroids do not act rapidly enough to replace epinephrine.

This remains one of the most important messages in allergy medicine.

---

A PRACTICAL RURAL PRIMARY CARE TOOLKIT

Adults

First-line:

✔ Bilastine

✔ Cetirizine

Alternatives:

✔ Levocetirizine

✔ Desloratadine

✔ Fexofenadine

✔ Rupatadine

✔ Ebastine

---

Pediatrics

First-line:

✔ Bilastine

✔ Cetirizine

Alternatives:

✔ Levocetirizine

✔ Desloratadine

---

Anaphylaxis

✔ Intramuscular epinephrine

Never antihistamines alone.

---

CONCLUSIONS

Spain and much of Europe are experiencing longer, more intense, and more environmentally driven allergy seasons than were observed two decades ago.

Climate change, air pollution, and increasing airborne allergen exposure are transforming the epidemiology of allergic disease.

The solution is not simply prescribing more corticosteroids.

The solution is selecting the right second-generation antihistamine, maintaining treatment long enough to control ongoing exposure, educating patients properly, and reserving corticosteroids for situations where they are genuinely necessary.

The modern clinical question is no longer:

"How do I treat this allergy?"

The modern question is:

"How do I prevent this patient from returning three times for the same problem?"

---

DrRamonReyesMD ⚕️
EMS Solutions International

Emergency Medicine • Primary Care • Practical Allergy Medicine • Pediatrics • Environmental Health • TACMED

“The best antihistamine is not the strongest one. It is the one that keeps the patient from coming back unnecessarily.”